Support the INSULIN Act to prevent health care plans from applying deductibles to select insulin products.

Diana DeGette · Colorado · Democratic

policy impact 0.60 specificity 0.78 extraction confidence 82%

Commitment kind: outcome. Promised action: Support the INSULIN Act's deductible prohibition for select insulin products.. Promised outcome: Health care plans do not apply deductibles to select insulin products.. Deadline: unknown; not assumed expired. U.S. Representative Diana DeGette press release on introducing the INSULIN Act in the 119th Congress.

Contest this claim

Occurrences

The INSULIN Act will: Cap out-of-pocket patient cost-sharing for individuals with insurance at $35 a month; Prohibit health care plans from applying any deductible to select insulin products; Help uninsured people with diabetes get access to insulin; and Get biosimilar insulin to market more quickly.

The press release says the INSULIN Act will prohibit health plans from applying deductibles to selected insulin products.

DeGette Delivers Bill to Cap Insulin Cost at $35 Per Month | Congresswoman Diana DeGette
primary · press_release · model gpt-5.5

Evidence

verified · Source version 65808 · locator 1347

Ms. DeGette (for herself, Mrs. Miller-Meeks, Ms. Schrier, Mr. Bresnahan, and Ms. Craig) introduced the following bill

Fetched verbatim passage. AI summary (separate from source): Official GovInfo metadata shows DeGette introduced H.R. 10227, the House INSULIN Act of 2026, during the lookback window. The action was referral to House committees, not enactment, so the commitment remains unresolved with clear effort.

unresolved same_term A for effort

H.R. 10227 (IH) - Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 - BILLS-119hr10227ih | Content Details | GovInfo
primary · model gpt-5.5 · confidence 98%

Contest this evidence item

unverified · Source version 52814 · locator unknown

shall provide coverage of selected insulin products, and with respect to such products, shall not-- ``(1) apply any deductible

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The introduced House bill text directly matches the claim by barring deductibles for selected insulin products, but it is only introduced bill text and has not become law.

unresolved same_term A for effort

H.R. 10227 Introduced in House Text - INSULIN Act of 2026 - GovInfo
secondary · model gpt-5.5 · confidence 97%

Contest this evidence item

verified · Source version 52809 · locator 1159

introduced the Improving Needed Safeguards for Users of Lifesaving Insulin Now (“INSULIN”) Act.

Fetched verbatim passage. AI summary (separate from source): DeGette's official office announced the House introduction one day after the bill date, confirming public support and sponsorship during the lookback window; it does not show enactment.

unresolved same_term A for effort

DeGette Delivers Bill to Cap Insulin Cost at $35 Per Month | Congresswoman Diana DeGette
primary · model gpt-5.5 · confidence 93%

Contest this evidence item

verified · Source version 52816 · locator 1340

Reported by Mr. Cassidy, with an amendment

Fetched verbatim passage. AI summary (separate from source): The Senate companion was reported in the Senate before the lookback window, indicating continued congressional movement but not final passage or enactment.

unresolved same_term

S. 4189 (RS) - Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 - BILLS-119s4189rs | Content Details | GovInfo
secondary · model gpt-5.5 · confidence 92%

Contest this evidence item

unverified · Source version 52820 · locator unknown

the deductible under paragraph (1) shall not apply with respect to any covered insulin product.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Current federal law already bars Medicare Part D deductibles for covered insulin products, which is a partial policy achievement for Medicare beneficiaries, but it does not satisfy the broader INSULIN Act coverage for private and all insured individuals.

partial unknown

[USC02] 42 USC 1395w-102: Prescription drug benefits
secondary · model gpt-5.5 · confidence 90%

Contest this evidence item

Assessments

Public state: unverified As of unknown · unverified · Source revision or retrieval eligibility changed; current packet requires reassessment.. Original AI recommendation (not independently established): unresolved. unknown

provider integrity · model deterministic · confidence 0%

Public state: pending As of 2026-09-14 · verified · . Original AI recommendation (not independently established): unresolved. unknown A for effort

The verified commitment promised the INSULIN Act would prohibit health care plans from applying deductibles to select insulin products. Verified evidence shows DeGette introduced the INSULIN Act, which is material effort attributable to her, but the verified passages do not show enactment or that health plans are legally barred from applying those deductibles. With no deadline expired as of 2026-09-14, the outcome remains unresolved rather than delivered or never.

provider codex_cli · model gpt-5.5 · confidence 94%